Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Community Health Systems
Providers
Half of CHS' Q2 volume gains were uninsured patients
Similar to its for-profit peer HCA Healthcare, CHS credited a higher-than-expected impact from disruption on the ACA exchanges for its poor quarter.
Dave Muoio
Jul 23, 2026 12:00pm
Healthcare Dealmakers—Ascension closes $3.9B Amsurg buy & more
Jul 6, 2026 10:00am
CHS sells 4 Arkansas hospitals to Freeman Health for $110M
Jun 1, 2026 9:30am
Healthcare Dealmakers—Orlando Health's Alabama push continues
May 5, 2026 7:00am
Here's what for-profit health system CEOs, CFOs made in 2025
Apr 27, 2026 5:00am
CHS blames consumer fears, payers for Q1's volumes dip
Apr 22, 2026 1:00pm
